nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.589	1	CrCrCtD
Cyproheptadine—Insomnia—Tamoxifen—pancreatic cancer	0.000833	0.00459	CcSEcCtD
Cyproheptadine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000827	0.00455	CcSEcCtD
Cyproheptadine—Insomnia—Erlotinib—pancreatic cancer	0.000824	0.00454	CcSEcCtD
Cyproheptadine—Chills—Irinotecan—pancreatic cancer	0.00082	0.00452	CcSEcCtD
Cyproheptadine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00081	0.00446	CcSEcCtD
Cyproheptadine—Dyspepsia—Erlotinib—pancreatic cancer	0.000802	0.00442	CcSEcCtD
Cyproheptadine—Decreased appetite—Tamoxifen—pancreatic cancer	0.0008	0.00441	CcSEcCtD
Cyproheptadine—Chills—Gemcitabine—pancreatic cancer	0.000799	0.0044	CcSEcCtD
Cyproheptadine—Fatigue—Tamoxifen—pancreatic cancer	0.000794	0.00437	CcSEcCtD
Cyproheptadine—Decreased appetite—Erlotinib—pancreatic cancer	0.000792	0.00436	CcSEcCtD
Cyproheptadine—Oedema—Sunitinib—pancreatic cancer	0.000788	0.00434	CcSEcCtD
Cyproheptadine—Constipation—Tamoxifen—pancreatic cancer	0.000787	0.00434	CcSEcCtD
Cyproheptadine—Fatigue—Erlotinib—pancreatic cancer	0.000785	0.00433	CcSEcCtD
Cyproheptadine—Constipation—Erlotinib—pancreatic cancer	0.000779	0.00429	CcSEcCtD
Cyproheptadine—Shock—Sunitinib—pancreatic cancer	0.000776	0.00427	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000772	0.00425	CcSEcCtD
Cyproheptadine—Anorexia—Sunitinib—pancreatic cancer	0.000752	0.00414	CcSEcCtD
Cyproheptadine—Urticaria—Tamoxifen—pancreatic cancer	0.000731	0.00403	CcSEcCtD
Cyproheptadine—Weight increased—Docetaxel—pancreatic cancer	0.000718	0.00396	CcSEcCtD
Cyproheptadine—Vision blurred—Fluorouracil—pancreatic cancer	0.000718	0.00396	CcSEcCtD
Cyproheptadine—Vertigo—Irinotecan—pancreatic cancer	0.000715	0.00394	CcSEcCtD
Cyproheptadine—Syncope—Irinotecan—pancreatic cancer	0.000714	0.00393	CcSEcCtD
Cyproheptadine—Insomnia—Sunitinib—pancreatic cancer	0.000713	0.00393	CcSEcCtD
Cyproheptadine—Leukopenia—Irinotecan—pancreatic cancer	0.000712	0.00392	CcSEcCtD
Cyproheptadine—Paraesthesia—Sunitinib—pancreatic cancer	0.000708	0.0039	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—pancreatic cancer	0.000702	0.00387	CcSEcCtD
Cyproheptadine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000699	0.00385	CcSEcCtD
Cyproheptadine—Dyspepsia—Sunitinib—pancreatic cancer	0.000694	0.00382	CcSEcCtD
Cyproheptadine—Leukopenia—Gemcitabine—pancreatic cancer	0.000694	0.00382	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00069	0.0038	CcSEcCtD
Cyproheptadine—Jaundice—Docetaxel—pancreatic cancer	0.000686	0.00378	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—pancreatic cancer	0.000686	0.00378	CcSEcCtD
Cyproheptadine—Decreased appetite—Sunitinib—pancreatic cancer	0.000685	0.00378	CcSEcCtD
Cyproheptadine—Leukopenia—Fluorouracil—pancreatic cancer	0.000682	0.00376	CcSEcCtD
Cyproheptadine—Fatigue—Sunitinib—pancreatic cancer	0.00068	0.00374	CcSEcCtD
Cyproheptadine—Constipation—Sunitinib—pancreatic cancer	0.000674	0.00371	CcSEcCtD
Cyproheptadine—Asthenia—Tamoxifen—pancreatic cancer	0.00066	0.00364	CcSEcCtD
Cyproheptadine—Convulsion—Fluorouracil—pancreatic cancer	0.00066	0.00364	CcSEcCtD
Cyproheptadine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000657	0.00362	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—pancreatic cancer	0.000656	0.00361	CcSEcCtD
Cyproheptadine—Confusional state—Irinotecan—pancreatic cancer	0.000655	0.00361	CcSEcCtD
Cyproheptadine—Asthenia—Erlotinib—pancreatic cancer	0.000653	0.0036	CcSEcCtD
Cyproheptadine—Oedema—Irinotecan—pancreatic cancer	0.000649	0.00358	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000649	0.00358	CcSEcCtD
Cyproheptadine—Shock—Irinotecan—pancreatic cancer	0.000639	0.00352	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000636	0.0035	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—pancreatic cancer	0.000634	0.00349	CcSEcCtD
Cyproheptadine—Oedema—Gemcitabine—pancreatic cancer	0.000633	0.00348	CcSEcCtD
Cyproheptadine—Hepatitis—Docetaxel—pancreatic cancer	0.000632	0.00348	CcSEcCtD
Cyproheptadine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00063	0.00347	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000628	0.00346	CcSEcCtD
Cyproheptadine—Confusional state—Fluorouracil—pancreatic cancer	0.000627	0.00345	CcSEcCtD
Cyproheptadine—Diarrhoea—Erlotinib—pancreatic cancer	0.000623	0.00343	CcSEcCtD
Cyproheptadine—Oedema—Fluorouracil—pancreatic cancer	0.000622	0.00343	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000619	0.00341	CcSEcCtD
Cyproheptadine—Anorexia—Irinotecan—pancreatic cancer	0.000619	0.00341	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—pancreatic cancer	0.000616	0.00339	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000612	0.00337	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000609	0.00335	CcSEcCtD
Cyproheptadine—Dizziness—Tamoxifen—pancreatic cancer	0.000609	0.00335	CcSEcCtD
Cyproheptadine—Tachycardia—Fluorouracil—pancreatic cancer	0.000607	0.00334	CcSEcCtD
Cyproheptadine—Hypotension—Irinotecan—pancreatic cancer	0.000607	0.00334	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—pancreatic cancer	0.000607	0.00334	CcSEcCtD
Cyproheptadine—Anorexia—Gemcitabine—pancreatic cancer	0.000603	0.00332	CcSEcCtD
Cyproheptadine—Dizziness—Erlotinib—pancreatic cancer	0.000602	0.00332	CcSEcCtD
Cyproheptadine—Anorexia—Fluorouracil—pancreatic cancer	0.000593	0.00327	CcSEcCtD
Cyproheptadine—Hypotension—Gemcitabine—pancreatic cancer	0.000591	0.00326	CcSEcCtD
Cyproheptadine—Insomnia—Irinotecan—pancreatic cancer	0.000587	0.00324	CcSEcCtD
Cyproheptadine—Vomiting—Tamoxifen—pancreatic cancer	0.000585	0.00322	CcSEcCtD
Cyproheptadine—Paraesthesia—Irinotecan—pancreatic cancer	0.000583	0.00321	CcSEcCtD
Cyproheptadine—Hypotension—Fluorouracil—pancreatic cancer	0.000581	0.0032	CcSEcCtD
Cyproheptadine—Rash—Tamoxifen—pancreatic cancer	0.00058	0.0032	CcSEcCtD
Cyproheptadine—Dermatitis—Tamoxifen—pancreatic cancer	0.00058	0.00319	CcSEcCtD
Cyproheptadine—Vomiting—Erlotinib—pancreatic cancer	0.000579	0.00319	CcSEcCtD
Cyproheptadine—Somnolence—Irinotecan—pancreatic cancer	0.000577	0.00318	CcSEcCtD
Cyproheptadine—Headache—Tamoxifen—pancreatic cancer	0.000577	0.00318	CcSEcCtD
Cyproheptadine—Rash—Erlotinib—pancreatic cancer	0.000574	0.00316	CcSEcCtD
Cyproheptadine—Dermatitis—Erlotinib—pancreatic cancer	0.000574	0.00316	CcSEcCtD
Cyproheptadine—Insomnia—Gemcitabine—pancreatic cancer	0.000572	0.00315	CcSEcCtD
Cyproheptadine—Dyspepsia—Irinotecan—pancreatic cancer	0.000572	0.00315	CcSEcCtD
Cyproheptadine—Headache—Erlotinib—pancreatic cancer	0.000571	0.00314	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—pancreatic cancer	0.00057	0.00314	CcSEcCtD
Cyproheptadine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000568	0.00313	CcSEcCtD
Cyproheptadine—Chills—Docetaxel—pancreatic cancer	0.000567	0.00312	CcSEcCtD
Cyproheptadine—Asthenia—Sunitinib—pancreatic cancer	0.000566	0.00312	CcSEcCtD
Cyproheptadine—Decreased appetite—Irinotecan—pancreatic cancer	0.000565	0.00311	CcSEcCtD
Cyproheptadine—Insomnia—Fluorouracil—pancreatic cancer	0.000563	0.0031	CcSEcCtD
Cyproheptadine—Somnolence—Gemcitabine—pancreatic cancer	0.000562	0.0031	CcSEcCtD
Cyproheptadine—Fatigue—Irinotecan—pancreatic cancer	0.00056	0.00308	CcSEcCtD
Cyproheptadine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000559	0.00308	CcSEcCtD
Cyproheptadine—Constipation—Irinotecan—pancreatic cancer	0.000555	0.00306	CcSEcCtD
Cyproheptadine—Somnolence—Fluorouracil—pancreatic cancer	0.000553	0.00305	CcSEcCtD
Cyproheptadine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00055	0.00303	CcSEcCtD
Cyproheptadine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000548	0.00302	CcSEcCtD
Cyproheptadine—Nausea—Tamoxifen—pancreatic cancer	0.000547	0.00301	CcSEcCtD
Cyproheptadine—Fatigue—Gemcitabine—pancreatic cancer	0.000545	0.003	CcSEcCtD
Cyproheptadine—Constipation—Gemcitabine—pancreatic cancer	0.000541	0.00298	CcSEcCtD
Cyproheptadine—Nausea—Erlotinib—pancreatic cancer	0.000541	0.00298	CcSEcCtD
Cyproheptadine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000541	0.00298	CcSEcCtD
Cyproheptadine—Diarrhoea—Sunitinib—pancreatic cancer	0.000539	0.00297	CcSEcCtD
Cyproheptadine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000535	0.00295	CcSEcCtD
Cyproheptadine—Dizziness—Sunitinib—pancreatic cancer	0.000521	0.00287	CcSEcCtD
Cyproheptadine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000521	0.00287	CcSEcCtD
Cyproheptadine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000513	0.00282	CcSEcCtD
Cyproheptadine—Vomiting—Sunitinib—pancreatic cancer	0.000501	0.00276	CcSEcCtD
Cyproheptadine—Rash—Sunitinib—pancreatic cancer	0.000497	0.00274	CcSEcCtD
Cyproheptadine—Dermatitis—Sunitinib—pancreatic cancer	0.000497	0.00274	CcSEcCtD
Cyproheptadine—Urticaria—Fluorouracil—pancreatic cancer	0.000494	0.00272	CcSEcCtD
Cyproheptadine—Headache—Sunitinib—pancreatic cancer	0.000494	0.00272	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—pancreatic cancer	0.000493	0.00272	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—pancreatic cancer	0.000492	0.00271	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—pancreatic cancer	0.000492	0.00271	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—pancreatic cancer	0.000486	0.00268	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000486	0.00268	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—pancreatic cancer	0.000485	0.00267	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000483	0.00266	CcSEcCtD
Cyproheptadine—Convulsion—Docetaxel—pancreatic cancer	0.000477	0.00263	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—pancreatic cancer	0.000475	0.00262	CcSEcCtD
Cyproheptadine—Nausea—Sunitinib—pancreatic cancer	0.000468	0.00258	CcSEcCtD
Cyproheptadine—Asthenia—Irinotecan—pancreatic cancer	0.000466	0.00257	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000465	0.00256	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—pancreatic cancer	0.000463	0.00255	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000455	0.00251	CcSEcCtD
Cyproheptadine—Asthenia—Gemcitabine—pancreatic cancer	0.000454	0.0025	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—pancreatic cancer	0.000453	0.00249	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00045	0.00248	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—pancreatic cancer	0.000449	0.00247	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—pancreatic cancer	0.000448	0.00247	CcSEcCtD
Cyproheptadine—Diarrhoea—Irinotecan—pancreatic cancer	0.000444	0.00245	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000443	0.00244	CcSEcCtD
Cyproheptadine—Shock—Docetaxel—pancreatic cancer	0.000442	0.00243	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00044	0.00242	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—pancreatic cancer	0.000439	0.00242	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—pancreatic cancer	0.000438	0.00241	CcSEcCtD
Cyproheptadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000433	0.00238	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000431	0.00237	CcSEcCtD
Cyproheptadine—Dizziness—Irinotecan—pancreatic cancer	0.000429	0.00237	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—pancreatic cancer	0.000428	0.00236	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—pancreatic cancer	0.000428	0.00236	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—pancreatic cancer	0.000426	0.00235	CcSEcCtD
Cyproheptadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000426	0.00234	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—pancreatic cancer	0.00042	0.00231	CcSEcCtD
Cyproheptadine—Vomiting—Irinotecan—pancreatic cancer	0.000413	0.00227	CcSEcCtD
Cyproheptadine—Dizziness—Fluorouracil—pancreatic cancer	0.000411	0.00227	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00041	0.00226	CcSEcCtD
Cyproheptadine—Rash—Irinotecan—pancreatic cancer	0.000409	0.00226	CcSEcCtD
Cyproheptadine—Dermatitis—Irinotecan—pancreatic cancer	0.000409	0.00225	CcSEcCtD
Cyproheptadine—Headache—Irinotecan—pancreatic cancer	0.000407	0.00224	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—pancreatic cancer	0.000406	0.00224	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—pancreatic cancer	0.000403	0.00222	CcSEcCtD
Cyproheptadine—Vomiting—Gemcitabine—pancreatic cancer	0.000402	0.00222	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—pancreatic cancer	0.000399	0.0022	CcSEcCtD
Cyproheptadine—Rash—Gemcitabine—pancreatic cancer	0.000399	0.0022	CcSEcCtD
Cyproheptadine—Dermatitis—Gemcitabine—pancreatic cancer	0.000399	0.0022	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—pancreatic cancer	0.000397	0.00219	CcSEcCtD
Cyproheptadine—Headache—Gemcitabine—pancreatic cancer	0.000396	0.00218	CcSEcCtD
Cyproheptadine—Vomiting—Fluorouracil—pancreatic cancer	0.000395	0.00218	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—pancreatic cancer	0.000395	0.00218	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—pancreatic cancer	0.000394	0.00217	CcSEcCtD
Cyproheptadine—Rash—Fluorouracil—pancreatic cancer	0.000392	0.00216	CcSEcCtD
Cyproheptadine—Dermatitis—Fluorouracil—pancreatic cancer	0.000392	0.00216	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—pancreatic cancer	0.00039	0.00215	CcSEcCtD
Cyproheptadine—Headache—Fluorouracil—pancreatic cancer	0.00039	0.00215	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—pancreatic cancer	0.000387	0.00213	CcSEcCtD
Cyproheptadine—Nausea—Irinotecan—pancreatic cancer	0.000386	0.00212	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—pancreatic cancer	0.000384	0.00211	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—pancreatic cancer	0.000382	0.00211	CcSEcCtD
Cyproheptadine—Nausea—Gemcitabine—pancreatic cancer	0.000376	0.00207	CcSEcCtD
Cyproheptadine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00037	0.00204	CcSEcCtD
Cyproheptadine—Nausea—Fluorouracil—pancreatic cancer	0.000369	0.00204	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—pancreatic cancer	0.000368	0.00203	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—pancreatic cancer	0.000364	0.00201	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—pancreatic cancer	0.00036	0.00199	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—pancreatic cancer	0.000354	0.00195	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—pancreatic cancer	0.00035	0.00193	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—pancreatic cancer	0.000341	0.00188	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—pancreatic cancer	0.000337	0.00186	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—pancreatic cancer	0.000333	0.00184	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—pancreatic cancer	0.000333	0.00184	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—pancreatic cancer	0.000333	0.00183	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—pancreatic cancer	0.000332	0.00183	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—pancreatic cancer	0.000328	0.00181	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000326	0.0018	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—pancreatic cancer	0.000324	0.00178	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—pancreatic cancer	0.000322	0.00177	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—pancreatic cancer	0.000321	0.00177	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—pancreatic cancer	0.000315	0.00174	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—pancreatic cancer	0.000308	0.0017	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—pancreatic cancer	0.000308	0.0017	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—pancreatic cancer	0.000307	0.00169	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—pancreatic cancer	0.000307	0.00169	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—pancreatic cancer	0.000305	0.00168	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—pancreatic cancer	0.000303	0.00167	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—pancreatic cancer	0.000303	0.00167	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000302	0.00166	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—pancreatic cancer	0.000298	0.00164	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—pancreatic cancer	0.000297	0.00164	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—pancreatic cancer	0.000297	0.00164	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000296	0.00163	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—pancreatic cancer	0.000296	0.00163	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000293	0.00161	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—pancreatic cancer	0.000289	0.00159	CcSEcCtD
Cyproheptadine—Vomiting—Docetaxel—pancreatic cancer	0.000285	0.00157	CcSEcCtD
Cyproheptadine—Rash—Docetaxel—pancreatic cancer	0.000283	0.00156	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—pancreatic cancer	0.000283	0.00156	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—pancreatic cancer	0.000283	0.00156	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—pancreatic cancer	0.000283	0.00156	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—pancreatic cancer	0.000281	0.00155	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—pancreatic cancer	0.00028	0.00154	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—pancreatic cancer	0.000276	0.00152	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000274	0.00151	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—pancreatic cancer	0.000274	0.00151	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—pancreatic cancer	0.000273	0.00151	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—pancreatic cancer	0.000272	0.0015	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000271	0.00149	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—pancreatic cancer	0.000269	0.00148	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—pancreatic cancer	0.000267	0.00147	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—pancreatic cancer	0.000267	0.00147	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—pancreatic cancer	0.000267	0.00147	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—pancreatic cancer	0.000263	0.00145	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—pancreatic cancer	0.000262	0.00144	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—pancreatic cancer	0.000261	0.00144	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—pancreatic cancer	0.000259	0.00143	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—pancreatic cancer	0.000253	0.0014	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000252	0.00139	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00025	0.00137	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—pancreatic cancer	0.000249	0.00137	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000247	0.00136	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000244	0.00134	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—pancreatic cancer	0.000242	0.00133	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—pancreatic cancer	0.000241	0.00133	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—pancreatic cancer	0.00024	0.00132	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000231	0.00127	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—pancreatic cancer	0.000223	0.00123	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—pancreatic cancer	0.000217	0.0012	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—pancreatic cancer	0.000207	0.00114	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—pancreatic cancer	0.000201	0.00111	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—pancreatic cancer	0.000193	0.00106	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000192	0.00106	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—pancreatic cancer	0.000191	0.00105	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—pancreatic cancer	0.000191	0.00105	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—pancreatic cancer	0.00019	0.00104	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—pancreatic cancer	0.000185	0.00102	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—pancreatic cancer	0.00018	0.000991	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—pancreatic cancer	0.000178	0.000981	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—pancreatic cancer	0.000177	0.000973	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—pancreatic cancer	0.000177	0.000972	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—pancreatic cancer	0.000176	0.000967	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—pancreatic cancer	0.000166	0.000917	CcSEcCtD
Cyproheptadine—HTR2A—Signaling Pathways—EGF—pancreatic cancer	1.64e-05	7.13e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.63e-05	7.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.63e-05	7.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.63e-05	7.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.63e-05	7.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.62e-05	7.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	1.62e-05	7.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.61e-05	7e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.61e-05	6.99e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SRC—pancreatic cancer	1.59e-05	6.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	1.57e-05	6.85e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	1.56e-05	6.81e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—pancreatic cancer	1.55e-05	6.74e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—pancreatic cancer	1.53e-05	6.68e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.53e-05	6.68e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NRAS—pancreatic cancer	1.53e-05	6.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	1.53e-05	6.65e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.52e-05	6.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	1.51e-05	6.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.51e-05	6.56e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	1.5e-05	6.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.5e-05	6.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.5e-05	6.53e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—pancreatic cancer	1.5e-05	6.53e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.5e-05	6.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.49e-05	6.49e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.48e-05	6.45e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.48e-05	6.44e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.47e-05	6.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.46e-05	6.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.46e-05	6.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.46e-05	6.34e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	1.45e-05	6.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SRC—pancreatic cancer	1.45e-05	6.32e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.45e-05	6.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.45e-05	6.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.44e-05	6.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.44e-05	6.28e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.44e-05	6.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.43e-05	6.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.43e-05	6.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.43e-05	6.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	1.42e-05	6.2e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—pancreatic cancer	1.42e-05	6.2e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	1.42e-05	6.19e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—pancreatic cancer	1.42e-05	6.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.42e-05	6.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.42e-05	6.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	1.41e-05	6.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.41e-05	6.15e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	1.41e-05	6.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	1.4e-05	6.11e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	1.4e-05	6.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	1.4e-05	6.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.4e-05	6.09e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	1.4e-05	6.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	1.39e-05	6.07e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—pancreatic cancer	1.39e-05	6.07e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.36e-05	5.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.36e-05	5.91e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	1.35e-05	5.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	1.34e-05	5.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.33e-05	5.79e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—pancreatic cancer	1.32e-05	5.73e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	1.31e-05	5.72e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	5.7e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	1.31e-05	5.7e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	5.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.3e-05	5.67e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.3e-05	5.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—pancreatic cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—pancreatic cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.3e-05	5.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	1.3e-05	5.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.29e-05	5.64e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.29e-05	5.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.29e-05	5.6e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	1.28e-05	5.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	1.27e-05	5.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	1.27e-05	5.53e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	1.27e-05	5.53e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	5.52e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	5.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	1.26e-05	5.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.26e-05	5.49e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	1.26e-05	5.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.25e-05	5.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.24e-05	5.4e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	1.24e-05	5.39e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	1.23e-05	5.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.23e-05	5.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	5.31e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	5.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.21e-05	5.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	1.21e-05	5.27e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—pancreatic cancer	1.21e-05	5.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	1.21e-05	5.26e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.21e-05	5.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.2e-05	5.25e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	1.2e-05	5.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	1.2e-05	5.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.2e-05	5.21e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.2e-05	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.19e-05	5.18e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.19e-05	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	5.13e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	1.18e-05	5.12e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.17e-05	5.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.17e-05	5.1e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	1.17e-05	5.1e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—pancreatic cancer	1.17e-05	5.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	1.17e-05	5.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	5.08e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.16e-05	5.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1.16e-05	5.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	1.16e-05	5.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	1.16e-05	5.04e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.15e-05	5.03e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.15e-05	4.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	1.15e-05	4.99e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.14e-05	4.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	1.14e-05	4.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	4.95e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.13e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.13e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.13e-05	4.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	1.13e-05	4.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	1.13e-05	4.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	1.13e-05	4.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	1.13e-05	4.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.12e-05	4.9e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.12e-05	4.89e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.12e-05	4.88e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	1.12e-05	4.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.12e-05	4.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.11e-05	4.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	1.11e-05	4.86e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.11e-05	4.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.1e-05	4.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.1e-05	4.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	1.1e-05	4.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.1e-05	4.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.1e-05	4.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	4.77e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.09e-05	4.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.09e-05	4.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.09e-05	4.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.09e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.09e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.08e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.08e-05	4.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	4.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	1.07e-05	4.65e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	4.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.06e-05	4.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.06e-05	4.62e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.05e-05	4.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.05e-05	4.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.05e-05	4.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.03e-05	4.5e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.03e-05	4.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	1.02e-05	4.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	4.43e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.01e-05	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.01e-05	4.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.01e-05	4.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.01e-05	4.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	9.98e-06	4.35e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	9.96e-06	4.34e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	9.94e-06	4.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	9.9e-06	4.31e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	9.88e-06	4.3e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	9.88e-06	4.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	9.85e-06	4.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	9.82e-06	4.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	9.8e-06	4.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	9.78e-06	4.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	9.78e-06	4.26e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	9.76e-06	4.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	9.75e-06	4.25e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	9.74e-06	4.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	9.73e-06	4.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	9.72e-06	4.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	9.72e-06	4.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	9.69e-06	4.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	9.69e-06	4.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	9.62e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	9.6e-06	4.18e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—pancreatic cancer	9.26e-06	4.03e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	9.23e-06	4.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	9.17e-06	3.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	9.11e-06	3.97e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—pancreatic cancer	9.09e-06	3.96e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	9.09e-06	3.96e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	9.07e-06	3.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	9.06e-06	3.95e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	9.05e-06	3.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.04e-06	3.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	9.03e-06	3.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	9.02e-06	3.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	9.01e-06	3.92e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	8.95e-06	3.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	8.94e-06	3.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	8.92e-06	3.89e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	8.91e-06	3.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	8.9e-06	3.88e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	8.89e-06	3.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	8.86e-06	3.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	8.83e-06	3.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	8.75e-06	3.81e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	8.66e-06	3.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	8.61e-06	3.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	8.55e-06	3.73e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	8.42e-06	3.67e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	8.4e-06	3.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	8.37e-06	3.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	8.34e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	8.28e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	8.26e-06	3.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	8.24e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	7.86e-06	3.42e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	7.73e-06	3.37e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	7.72e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	7.69e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	7.67e-06	3.34e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—pancreatic cancer	7.6e-06	3.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	7.59e-06	3.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—pancreatic cancer	7.49e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	7.48e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—pancreatic cancer	7.46e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	7.44e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	7.42e-06	3.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	7.34e-06	3.2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	7.31e-06	3.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	7.27e-06	3.17e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	7.27e-06	3.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	7.15e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	7.14e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	7.12e-06	3.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	7.09e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	7.02e-06	3.06e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	6.42e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	6.32e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	6.3e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	6.28e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	6.26e-06	2.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	6.2e-06	2.7e-05	CbGpPWpGaD
